IL-23 is a key cytokine in promotion of chronic inflammation. Here, we address if its pro-inflammatory potential can be harnessed to protect against chronic cryptococcosis. Mice were infected with Cryptococcus neoformans and treated with recombinant IL-23. Administration of IL-23 led to prolonged survival and reduced fungal burden but was inferior to IL-12 treatment. Independent of endogenous IL-23/IL-12, IL-23 treatment induced an altered cytokine profile accompanied by marked changes in composition of the inflammatory infiltrate characterized by T cell and dendritic cell recruitment. Although IL-23 induced hallmarks of the T h 17 pathway, also non-T cells produced IL-17A and IL-22. IL-23 treatment of T-cell-deficient mice resulted in increased IL-17A and IL-22 production and modulation of the cellular response at the site of infection with elevated expression of CD86 on macrophages. Our data show that IL-23 treatment induces innate and adaptive tissue inflammation with limited impact on resistance to chronic cryptococcosis.
Introduction
IL-23 is a heterodimeric cytokine composed of the same p40 subunit as IL-12 and a unique 19-kDa subunit p19 (1) . The potent pro-inflammatory functions of IL-23 are crucial in various models of chronic autoimmune inflammation. Mice deficient for IL-23 are resistant to autoimmune arthritis, encephalitis and colitis (1) . Resistance in these models was associated with the lack of a novel IL-17 producing T h cell subset. Meanwhile, those cells are accepted as a bona fide T-cell lineage, T h 17. In mice, an important role for IL-6/ transforming growth factor-b/IL-21 in the initiation of T h 17 development could be shown while IL-23 seems to be the key factor for the maintenance of such a response (2) . In a recent publication, T h 17 cells were found to be induced by fungal cell wall components of pathogenic yeasts (3, 4) . Besides its important function on pathogenic T cells, IL-23 seems to play a more versatile role in the immune system. Recently, IL-23 was shown to induce colitis independently of T cells (5) . Interestingly, even in the absence of T cells, IL-23-dependent expression of IL-17A and IL-22 could be detected in the inflamed colon (6, 7) .
While most of the current literature describes the potent pro-inflammatory role of IL-23 in a context of autoimmune disease, cell-mediated immunity is also an important feature of protective immune responses against intracellular infections. Previously, we and others have reported that mice lacking the p40 subunit of IL-12/IL-23 are more susceptible to chronic infection with intracellular pathogens than mice lacking the p35 subunit of IL-12 (8) (9) (10) (11) (12) . In the absence of IL-12, reconstitution of such highly susceptible mice with recombinant IL-23 led to significantly enhanced resistance in models of Cryptococcus neoformans and Toxoplasma gondii infection (12) . While IL-12 has been demonstrated to be an essential player in cell-mediated immunity, these new data pointed to an important role of IL-23 in immune responses to intracellular infections such as cryptococcosis and toxoplasmosis, when IL-12 is absent. However, infection of mice that specifically lack IL-23 while still able to produce IL-12 [IL-23p19 À/À mice (13) ] revealed that IL-12-mediated protection was superior to the limited protective effects of endogenous IL-23 (12) .
We now addressed if by use of recombinant IL-23, its pro-inflammatory effects can be harnessed to fight fungal pathogens. To this end, we characterized the effects of exogenous IL-23 in C. neoformans infection. C. neoformans var. neoformans is an encapsulated facultative intracellular yeast (14) . This opportunistic pathogen causes meningoencephalitis in immunodeficient hosts. It is the most common lethal fungal infection in AIDS patients with central nervous system disease (15) . IL-12, IFN-c, tumor necrosis factor (TNF)-a and inducible nitric oxide synthase play a central role in protective immune responses to C. neoformans (8, (16) (17) (18) (19) . T cells and macrophages are the predominant cell types that characterize the granulomatous inflammatory response associated with protection against C. neoformans infection in patients as well as in mouse models (15, (20) (21) (22) (23) . Our results demonstrate a role of recombinant IL-23 treatment in enhancing the inflammatory cell response and promoting production of a distinct cytokine and chemokine profile. Interestingly, pro-inflammatory effects were seen in the presence and absence of functional T cells displaying limited effects on protection.
Methods

Mice
C57BL/6J mice were bred and maintained in the animal facility at the Institute of Immunology, College of Veterinary Medicine, University of Leipzig. C57BL/6J wild-type (WT) and IL-12/IL-23p40 À/À and Rag2 À/À mice on a C57BL/6J background were maintained at Schering-Plough Biopharma (DNAX). Rag1 À/À mice on a C57BL/6J background were obtained from Jackson laboratories (Bar Harbor, ME, USA). All animal procedures were approved by the Institutional Animal Care and Usage Committee (IACUC) of the Landesdirektion Leipzig/Germany or Schering-Plough Biopharma/ DNAX IACUC. Female mice were used at 8-12 weeks of age. As Rag1 À/À and Rag2 À/À mice were not different in the parameters of infection and immunity that were investigated in our study, they are referred to as Rag-deficient mice in this report.
C. neoformans, infection, in vivo cytokine treatment
Encapsulated C. neoformans, strain 1841, serotype D, was used as described previously (8) . The acapsular C. neoformans serotype D strain CAP67 was kindly provided by Dr Bettina Fries, Albert-Einstein College of Medicine, Bronx, NY, USA, and cultivated and maintained in the same manner as strain 1841 (8) . Mice were infected intra-peritoneally (i.p.) with 10 000 CFU of C. neoformans strain 1841. Recombinant murine IL-23 was expressed and purified as described (24) and administered at 2 lg per mouse per day. Recombinant murine IL-12 was provided as a kind gift by Dr Maurice Gately. IL-12 was dosed at 0.1 lg per mouse per day. Treatment was administered daily i.p. beginning 2 days prior to infection. For survival experiments, daily treatment up to day 20 post-infection was continued thereafter twice a week until the end of the observation period.
Determination of survival rate and fungal burden Infected mice were monitored daily for morbidity and mortality. At time points indicated fungal burden was determined in organs (organ harvest using sterile technique) and the peritoneal cavity (peritoneal lavage with PBS/EDTA). Organs were weighed, dissected and homogenized in PBS using an Ultra-Turrax (T8; IKA-Werke, Staufen, Germany). Serial dilutions of peritoneal lavage fluids and organ homogenates were plated on Sabouraud dextrose agar plates and cryptococcal colonies were counted after 48-72 h of incubation at 30°C.
Flow cytometry
The cellular fraction of the peritoneal lavage recovery was incubated with 2 lg anti-mouse CD16/CD32 mAb (Fc Block TM , BD, Franklin Lakes, NJ, USA) in 10 ll buffer (3% FCS, 0.1% NaN 3 in PBS) per 10 6 cells. Such peritoneal exudates cells (PEC) were then stained with the indicated fluorophorconjugated mAbs each at 500 ng per 10 6 cells following standard protocols. For each sample, an unstained and an unspecific Ig isotype control was added.
Splenocyte cultures and ex vivo stimulation
At time points indicated, mice were sacrificed and spleens were taken and passed through a 100-lm mesh. The retrieved splenocyte single-cell suspension was cleared from red blood cells using RBC lysis buffer (Sigma), adjusted to 5 3 10 6 cells ml
À1
, plated in 24-well plates and stimulated after 2 h initial incubation at 37°C in a humidified CO 2 enriched (5%) atmosphere. For polyclonal stimulation, ConA (, 5 lg ml À1 ) or LPS (500 ng ml À1 ) were added. For antigen-specific re-stimulation, the weakly virulent acapsular C. neoformans strain CAP67, serotype D, was used as it was found to have better restimulatory capacities than a highly virulent encapsulated strain [M. A. Kleinschek and G. Alber, unpublished results, (25) ]. Splenocytes were either stimulated with viable (10 6 cells ml
) or heat-killed (10 7 cells ml À1 ) C. neoformans organisms. After 48 h incubation, supernatants were taken and stored at À20°C until further processed.
Cytokines, chemokines, IgE and nitric oxide determination
Splenocyte culture supernatants, sera and peritoneal lavage fluids were assayed using the Beadlyte Mouse MultiCytokine Detection System 2 and additional IL-17 and MCP-1 beadsets, following the manufacturer's recommendations (Upstate Biotechnology, Lake Placid, NY, USA). For assessment of IL-22, the R&D Quantikine ELISA kit was used. IgE concentration was determined by sandwich ELISA using the capture antibody R32-72 (BD Pharmingen) and a biotinylated anti-mouse-IgE antibody (BD Pharmingen; R35-118) for detection after incubation with peroxidase-labeled streptavidin (Southern Biotech Associates, Birmingham, AL, USA) and tetramethyl benzidine together with hydrogen peroxide as substrate (KPL, Gaithersburg, MD, USA). NO 3 in sera was first reduced to NO 2 by incubating the samples for 30 min with nitrate reductase (0.25 U ml À1 ) in the presence of 100 lM NADPH (Roche, Nutley, NJ, USA). Samples were then incubated with Griess reagent in the dark at room temperature. NO 2 concentration was measured at 570 nm wavelength on a plate reader (Molecular Devices, Sunnyvale, CA, USA).
Quantitative reverse transcription-PCR
Total RNA was prepared from frozen PEC pellets using RNeasy kit (Qiagen, Valencia, CA, USA) according to the manufacturer's protocol. Five micrograms of total RNA was reverse transcribed with oligo p(dT)15 (Roche) and random hexamers (Promega, Madison, WI, USA) following elimination of genomic DNA by DNAse I digestion (Ambion, Austin, TX, USA). Cytokine-, chemokine-and cell markerspecific mRNA was measured using real-time quantitative PCR (ABI 5700) with SYBR Green PCR Mastermix (Applied Biosystems, Foster City, CA, USA) as described previously (26) . Gene expression levels were normalized to expression of the housekeeping gene ubiquitin for each sample; relative expression levels of infected mice were further normalized to naive controls and compared between groups as x-fold up-regulation.
Statistical analysis
Mann-Whitney rank sum test or Kruskal-Wallis statistics followed by Dunns post-test were performed. Survival proportions were displayed using the Kaplan-Meier method; statistical differences were assessed by the Log rank test. Statistical significance was defined by a P value <0.05.
Results
IL-23 treatment provides limited protection in C. neoformans infection without altering the T h 1/T h 2 balance
To determine if exogenous IL-23 can mediate protective effects in cryptococcosis, C57BL/6J mice were infected with C. neoformans and treated with IL-23, IL-12 (positive control) or PBS (negative control) starting 2 days prior to infection, continued daily until day 20 p.i. and twice a week thereafter. Consistent with a previous report (8) , IL-12 treatment resulted in 100% survival over the complete observation period in contrast to the PBS treatment (78% mortality) (Fig. 1A) . The administration of IL-23 led to prolonged survival periods; however, 40% of the IL-23-treated mice died up to day 100 p.i. (Fig. 1A) . Both IL-23 and IL-12 treatment resulted in similarly reduced fungal burden at the site of infection, the peritoneal cavity, at day 8 p.i. (Fig. 1B) and at day 21 p.i. also in brain and liver (Fig. 1C and D) . However, at a later time point (i.e. 100 dpi) in IL-23 treated mice, a median organ burden that was 5000-fold higher than in IL-12 treated mice was observed consistent with their reduced survival (data not shown). Thus, IL-23 provides limited protection as compared with IL-12 treatment. In accordance with the different cytokine profile (Fig. 1E ) and clinical outcome (Fig. 1A) following IL-12 versus IL-23 treatment, mice treated with IL-12 showed stronger inflammatory foci than upon IL-23 treatment at days 3 and 21 p.i. (data not shown).
While T h 1 cells are crucially important for clearance of C. neoformans infection (8, 17) , the development of a T h 2 response is detrimental for the host (8, 27) . Levels of the T h 2-associated Ig class IgE in IL-23-treated mice are comparable to PBS-treated mice at 21 dpi (Fig. 1E) . In contrast, IL-12 treatment led to a pronounced production of the T h 1-associated cytokine IFN-c as well as TNF-a and the effector molecule nitric oxide, whereas all these factors were below detection limit following either IL-23 or PBS treatment (Fig. 1E) . IL-17A and IL-22 were not detectable in sera at either time point (data not shown). These data indicate that treatment with IL-23 provides limited protection in C. neoformans infection that in contrast to IL-12 treatment is not mediated by alteration of the T h 1/T h 2 balance.
IL-23 treatment induces key cytokines of the T h 17 pathway
To address the molecular mechanisms of the IL-23-mediated effects independently of endogenous IL-12 and IL-23, we used mice deficient for endogenous IL-23 and IL-12, i.e. IL-12/IL-23p40-deficient (p40 À/À ) mice. We have previously shown that such mice display prolonged survival periods during cryptococcosis in response to IL-23 treatment (28) . Analysis of the processes at the site of infection, the peritoneal cavity, revealed reduced fungal burden in IL-23-treated p40-deficient mice at 8 dpi ( Fig. 2A ) associated with elevated mRNA levels of IL-17A in PEC obtained by lavage (Fig. 2B) . IL-17A protein, however, was not detectable in the peritoneal lavage fluids (data not shown). The cryptococcal antigen-specific recall response in splenocyte cultures from infected mice was characterized by elevated protein expression of IL-17A and IL-22 in the IL-23-treated group which was even more pronounced when cells were stimulated with a polyclonal stimulus (ConA) (Fig. 2C) . In addition, elevated levels of the pro-inflammatory cytokines IL-1b, TNF-a and IL-6 were prominent in the IL-23-treated group after stimulation with either viable (vCn) or heat-killed C. neoformans organisms (hkCn). It is noteworthy that administration of IL-23 induced these pro-inflammatory cytokine independently of endogenous IL-12 and IL-23. In naive mice, no differences could be seen between PBS and IL-23 treatment groups in ConA-induced splenic production of IL-17A, IL-6 or TNFa (data not shown).
IL-23 enhances the cellular immune response at the site of infection
To assess the effect of exogenous IL-23 on the cellular composition of the inflammatory infiltrates at infected sites, PEC were taken from IL-23-and mock-treated p40-deficient mice 8 days after i.p. infection with C. neoformans. Total cell counts were comparable between both treatment groups (Fig. 3A) . A flow cytometric comparison of PEC from both treatment groups by size and granularity did not reveal apparent differences (Fig. 3B) . Analysis of lymphocyte populations (small gate in Fig. 3B ) revealed that IL-23 treatment resulted in a significantly higher frequency of TCR-b + cells (Fig. 3C, upper panel) . Interestingly, the same trend was IL-23 therapy in fungal infection 83 seen for NK1.1 + cells (Fig. 3C, lower panel) . The percentage of CD11c
+ cells of all viable PEC (large gate in Fig. 3B ) was significantly higher in the IL-23-treated group (Fig. 3D) , whereas F4/80 + cells and Gr1 + cells did not differ in frequency (data not shown). Taken together, independently of endogenous IL-12/IL-23, IL-23 treatment leads to significantly enhanced infiltration of T cells and dendritic cells (DCs) at the site of infection.
IL-23 activates innate immune cells independently of T h 17
IL-23 is most characteristically associated with a recently described T h cell lineage termed T h 17 (2) . To address the question if the pro-inflammatory activity of IL-23 treatment observed in Cryptococcus-infected WT and p40-deficient mice relies on T-cell-dependent mechanisms, we infected Rag-deficient mice (Rag1 À/À or Rag2 À/À ) that lack functional T and B cells with C. neoformans and treated them with IL-23 or PBS. At day 8 p.i., IL-23-treated Rag-deficient mice had a significantly reduced fungal burden at the site of infection (Fig. 4A) . Moreover, expression of pro-inflammatory cytokines such as IL-22, IL-1b, IL-6 and TNF-a as well as the chemokine MCP-1 were strongly enhanced after IL-23 treatment, in contrast to IFN-c which was not elevated in peritoneal exudate lavage fluids of either group (Fig. 4B ). Paralleling these findings, an ex vivo analysis of the activation of innate immune cells in the spleen revealed a pronounced expression of IL-22, IL-1b, IL-6 and TNF-a, and also IL-17A in IL-23-treated Rag-deficient mice (Fig. 4C) . Interestingly, production of IL-17A and IL-1b in Rag-deficient mice was substantially lower than in IL-12/IL-23p40-deficient mice (Fig. 4C versus Fig. 2C ) indicating T-cell-dependent production of IL-17A and IL-1b. Next, we wished to explore the cellular basis for the T-cellindependent local IL-23 effects. Therefore, PEC of IL-23-or mock-treated Rag-deficient mice were analyzed at day 8 p.i. Total cell counts were not different between both treatment groups (Fig. 5A ) but lower in Rag-deficient mice than in WT mice (Fig. 5A versus Fig. 3A) . Moreover, analysis for size and granularity of PEC in both treatment groups showed no difference (Fig. 5B) . Staining for cell type-specific surface antigens on viable PEC, however, revealed a significantly higher percentage of NK1.1 + (Fig. 5D ), CD11c + (Fig. 5C ) and Gr1 + (Fig. 5E) 
IL-23 therapy in fungal infection 85
Downloaded from https://academic.oup.com/intimm/article-abstract/22/2/81/865647 by guest on 05 November 2018 treatment groups (Fig. 5F) . However, further analysis of these cells revealed differences in their activation status: a higher frequency of F4/80 + cells expressed F4/80 at a high level (Fig. 5G) . B7 molecules CD80 and CD86 are important co-stimulators of a T-cell response. In C. neoformans infection, the role of CD86 for a lymphoproliferative response is more important than that of CD80 (29) and in vitro incubation of APC with C. neoformans increases the expression of CD86 (30) . Indeed, the expression of the co-stimulatory molecule CD86 by F4/80 + cells was higher following IL-23 treatment ( Fig. 5H and I) . The expression on F4/80 + cells was also elevated for MHC-II and CD40 (data not shown). In + cells. For statistical analysis of CD11c percentages, the outlier (27.1%) observed in the PBS group was excluded. Scatter plots show cumulative data of two individually performed experiments (n = 3-5 mice in each experiment). Representative FACS plots show representative data of one mouse per treatment group; *P < 0.05. contrast, IL-23 treatment had no direct effect on the expression of F4/80 or CD86 on isolated macrophages (data not shown). These data demonstrate that the IL-23-dependent elevated expression of chemokines, cytokines and of costimulatory molecules does not rely on the presence of lymphocytes. Moreover, IL-23 treatment is able to enhance the cellular immune response comprising granulocytes, NK cells, macrophages and DCs. 
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production was markedly enhanced in the IL-23-treated group. Recently, the role for IL-23 in promoting an IL-17 producing T-cell subset which is meanwhile considered a bona fide T h cell lineage distinct from T h 1 and T h 2 could be defined. Besides IL-17A, this T-cell subset (T h 17) was shown to produce IL-6 and TNF-a, both of which were found in elevated levels in the study presented here. T h 17 cells have been shown to be key players in several models of chronic inflammation. Although their role in immune responses to infection is less defined, in acute Toxoplasma, Klebsiella and Candida infection IL-17A induced a beneficial immune response (12, (33) (34) (35) (36) (37) . Interestingly, for Candida infection, different outcomes were found for different models. IL-23-dependent T h 17 was either protective when Candida was given sublingually or even detrimental in case of intragastric infection (37, 38) .
IL-17 production during infection is mostly dependent on IL-23 and is commonly attributed to T cells. However, herein, we report that treatment of infected Rag-deficient mice with IL-23 despite the lack of an adaptive immune response induced IL-6, IL-1b, TNF-a, MCP-1 as well as IL-17 and IL-22 production. These findings are supported by a study of murine tuberculosis showing that the majority of IL-17 producers is not CD4 + T cells but rather c/d T cells and also other non-CD4
+ CD8 + cells (39) . Since the innate immune system provides the first line of defense against invading pathogens, the above observations lead to the understanding of the IL-23/IL-17/IL-22 pathway as an immediate response mechanism to infection as shown recently for Salmonella infection (40) .
Although we and others provide evidence for direct pro-inflammatory effects of IL-23 on the innate immune system, the underlying mechanisms are not completely defined. In immune responses to cryptococcal infection, the most important innate immune cells are DCs, macrophages and NK cells, while the contribution of neutrophils to resistance or susceptibility appears to depend on the route of infection and/or the time point during infection (41) . Our finding of increased macrophage activation following IL-23 treatment is intriguing and points to two possible mechanisms of action for exogenous IL-23 in Rag-deficient mice: (i) IL-23 directly activates macrophages and (ii) IL-23 activates cells such as NK cells or DCs, which then produce factors activating macrophages. Both hypotheses find support in the literature. Parham et al. (42) showed that message for the IL-23R is expressed not only on T cells but also on macrophages and NK cells. Also, IL-23R expression was found to be rapidly up-regulated on LPS-or Salmonella-activated bone marrowderived macrophages (43) . However, in vitro stimulation of murine bone marrow-derived macrophages with C. neoformans did not lead to detectable production of cytokines such as IL-12/23p40 or TNF-a or up-regulation of cell surface proteins involved in antigen presentation (30) . In vivo, Cua et al. (13) showed an activating effect on peritoneal macrophages by injecting recombinant IL-23 in the peritoneal cavity of mice. Peritoneal macrophages obtained by peritoneal lavage were shown to express higher mRNA levels for IL-1b and TNF-a. 
